Stockreport

Recursion and Enamine Release New AI-Enabled Targeted Compound Libraries

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF Kyiv, Ukraine and Salt Lake City, UT, April 09, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radical [Read more]